Doxorubicin‑induced oxidative and nitrosative stress: Mitochondrial connexin 43 is at the crossroads

Pecoraro,Michela; Pala,Barbara; Di Marcantonio,Maria Carmela; Muraro,Raffaella; Marzocco,Stefania; Pinto,Aldo; Mincione,Gabriella; Popolo,Ada

doi:10.3892/ijmm.2020.4669

Doxorubicin‑induced oxidative and nitrosative stress: Mitochondrial connexin 43 is at the crossroads

Authors:
- Michela Pecoraro
- Barbara Pala
- Maria Carmela Di Marcantonio
- Raffaella Muraro
- Stefania Marzocco
- Aldo Pinto
- Gabriella Mincione
- Ada Popolo
View Affiliations

Affiliations: Department of Pharmacy, University of Salerno, I-84084 Fisciano (SA), Italy, Department of Medical, Oral and Biotechnological Sciences, ‘G. d'Annunzio’ University of Chieti‑Pescara, I-66100 Chieti, Italy
Published online on: July 6, 2020 https://doi.org/10.3892/ijmm.2020.4669
Pages: 1197-1209
Copyright: © Pecoraro et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oxidative stress is widely accepted as a key factor of doxorubicin (Doxo)‑induced cardiotoxicity. There is evidence to indicate that nitrosative stress is involved in this process, and that Doxo interacts by amplifying cell damage. Mitochondrial connexin 43 (mitoCx43) can confer cardioprotective effects through the reduction of mitochondrial reactive oxygen species production during Doxo‑induced cardiotoxicity. The present study aimed to evaluate the involvement of mitoCx43 in Doxo‑induced nitrosative stress. Rat H9c2 cardiomyoblasts were treated with Doxo in the absence or presence of radicicol, an inhibitor of Hsp90, the molecular chaperone involved in Cx43 translocation to the mitochondria that underlies its role in cardioprotection. FACS analysis and RT‑qPCR revealed that Doxo increased superoxide dismutase, and catalase gene and protein expression. As shown by hypodiploid nuclei and confirmed by western blot analysis, Doxo increased caspase 9 expression and reduced procaspase 3 levels, which induced cell death. Moreover, a significant increase in the activation of the NF‑κB signaling pathway was observed. It is well known that the increased expression of inducible nitric oxide synthase results in nitric oxide overproduction, which then rapidly reacts with hydrogen peroxide or superoxide generated by the mitochondria, to form highly reactive and harmful peroxynitrite, which ultimately induces nitrotyrosine formation. Herein, these interactions were confirmed and increased effects were observed in the presence of radicicol. On the whole, the data of the present study indicate that an interplay between oxidative and nitrosative stress is involved in Doxo‑induced cardiotoxicity, and that both aspects are responsible for the induction of apoptosis. Furthermore, it is demonstrated that the mechanisms that further increase mitochondrial superoxide generation (e.g., the inhibition of Cx43 translocation into the mitochondria) significantly accelerate the occurrence of cell death.

View Figures

View References

1	Michela P, Velia V, Aldo P and Ada P: Role of connexin43 in cardiovascular diseases. Eur J Pharmacol. 768:71–76. 2015. View Article : Google Scholar : PubMed/NCBI
2	Severs NJ, Bruce AF, Dupont E and Rothery S: Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res. 80:9–19. 2008. View Article : Google Scholar : PubMed/NCBI
3	Fontes MS, van Veen TA, de Bakker JM and van Rijen HV: Functional consequences of abnormal Cx43 expression in the heart. Biochim Biophys Acta. 1818:2020–2029. 2012. View Article : Google Scholar
4	Ruiz-Meana M, Rodríguez-Sinovas A, Cabestrero A, Boengler K, Heusch G and Garcia-Dorado D: Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury. Cardiovasc Res. 77:325–333. 2008. View Article : Google Scholar
5	Boengler K, Stahlhofen S, van de Sand A, Gres P, Ruiz-Meana M, Garcia-Dorado D, Heusch G and Schulz R: Presence of connexin 43 in subsarcolemmal, but not in interfibrillar cardiomyocyte mitochondria. Basic Res Cardiol. 104:141–147. 2009. View Article : Google Scholar : PubMed/NCBI
6	Heinzel FR, Luo Y, Li X, Boengler K, Buechert A, García-Dorado D, Di Lisa F, Schulz R and Heusch G: Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ Res. 97:583–586. 2005. View Article : Google Scholar : PubMed/NCBI
7	Rehling P, Brandner K and Pfanner N: Mitochondrial import and the twin-pore translocase. Nat Rev Mol Cell Biol. 5:519–530. 2004. View Article : Google Scholar : PubMed/NCBI
8	Lu G, Haider HKH, Porollo A and Ashraf M: Mitochondria-specific transgenic overexpression of connexin-43 simulates preconditioning-induced cytoprotection of stem cells. Cardiovasc Res. 88:277–286. 2010. View Article : Google Scholar : PubMed/NCBI
9	Pecoraro M, Sorrentino R, Franceschelli S, Del Pizzo M, Pinto A and Popolo A: Doxorubicin-mediated cardiotoxicity: Role of mitochondrial connexin 43. Cardiovasc Toxicol. 15:366–376. 2015. View Article : Google Scholar : PubMed/NCBI
10	Pecoraro M, Ciccarelli M, Fiordelisi A, Iaccarino G, Pinto A and Popolo A: Diazoxide improves mitochondrial connexin 43 expression in a mouse model of doxorubicin-induced cardiotox-icity. Int J Mol Sci. 19:7572018. View Article : Google Scholar
11	Kondru SK, Potnuri AG, Allakonda L and Konduri P: Histamine 2 receptor antagonism elicits protection against doxorubicin-induced cardiotoxicity in rodent model. Mol Cell Biochem. 441:77–88. 2018. View Article : Google Scholar
12	Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ and Moens AL: Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol. 52:1213–1225. 2012. View Article : Google Scholar : PubMed/NCBI
13	Berthiaume JM and Wallace KB: Persistent alterations to the gene expression profile of the heart subsequent to chronic doxorubicin treatment. Cardiovasc Toxicol. 7:178–191. 2007. View Article : Google Scholar : PubMed/NCBI
14	Angsutararux P, Luanpitpong S and Issaragrisil S: Chemotherapy-induced cardiotoxicity: Overview of the roles of oxidative stress. Oxid Med Cell Longev. 2015:7956022015. View Article : Google Scholar : PubMed/NCBI
15	Mukhopadhyay P, Rajesh M, Bátkai S, Kashiwaya Y, Haskó G, Liaudet L, Szabó C, Pacher P and Am J: Role of superoxide nitric oxide and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Physiol Heart Circ Physiol. 296:H1466–H1483. 2009. View Article : Google Scholar
16	Pacher P, Beckman JS and Liaudet L: Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 87:315–424. 2007. View Article : Google Scholar : PubMed/NCBI
17	Tsutsui H, Kinugawa S and Matsushima S: Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol. 301:H2181–H2190. 2011. View Article : Google Scholar : PubMed/NCBI
18	Xu Z, Lin S, Wu W, Tan H, Wang Z, Cheng C, Lu L and Zhang X: Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF-kappaB pathways and mitochondrial protective mechanisms. Toxicology. 247:133–138. 2008. View Article : Google Scholar : PubMed/NCBI
19	Shirazi LF, Bissett J, Romeo F and Jawahar LM: Role of Inflammation in heart failure. Curr Atheroscl Rep. 19:272017. View Article : Google Scholar
20	Bartekova M, Radosinska J, Jelemensky M and Dhalla NS: Role of cytokines and inflammation in heart function during health and disease. Heart Failure Rev. 23:733–758. 2018. View Article : Google Scholar
21	Sanskriti K, Gurinder BS and Madhu K: Nitric oxide synthase and diabetic cardiomyopathy. Nitric Oxide. 43:29–34. 2014. View Article : Google Scholar
22	Schulte TW, Akinaga S, Soga S, Sullivan W, Stensgard B, Toft D and Neckers LM: Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin. Cell Stress Chaper. 3:100–108. 1998. View Article : Google Scholar
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
24	Boengler K, Dodoni G, Rodriguez-Sinovas A, Cabestrero A, Ruiz-Meana M, Gres P, Konietzka I, Lopez-Iglesias C, Garcia-Dorado D, Di Lisa F, et al: Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res. 67:234–244. 2005. View Article : Google Scholar : PubMed/NCBI
25	Di Iorio B, Marzocco S, Di Micco L, Adesso S, De Blasio A, Autore G, Sirico ML, Fazeli G and Heidland A: High-tone external muscle stimulation in patients with acute kidney injury (AKI): Beneficial effects on NO metabolism asymmetric dimethylarginine and endothelin-1. Clin Nephrol. 82:304–312. 2014. View Article : Google Scholar : PubMed/NCBI
26	Miao L and St Clair DK: Regulation of superoxide dismutase genes: Implications in disease. Free Radic Biol Med. 47:344–356. 2009. View Article : Google Scholar : PubMed/NCBI
27	Wallace DC: Mitochondrial defects in cardiomyopathy and neuromuscular disease. Am Heart J. 139:S70–S85. 2000. View Article : Google Scholar : PubMed/NCBI
28	Pecoraro M, Del Pizzo M, Marzocco S, Sorrentino R, Ciccarelli M, Iaccarino G, Pinto A and Popolo A: Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity. Toxicol Appl Pharmacol. 293:44–52. 2016. View Article : Google Scholar : PubMed/NCBI
29	Ueno M, Kakinuma Y, Yuhki K, Murakoshi N, Iemitsu M, Miyauchi T and Yamaguchi I: Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in Vitro and rat cardiac ventricles in Vivo. J Pharmacol Sci. 101:151–158. 2006. View Article : Google Scholar : PubMed/NCBI
30	Ghosh J, Das J, Manna P and Sil PC: The protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosis. Biomaterials. 32:4857–4866. 2011. View Article : Google Scholar : PubMed/NCBI
31	Del Prete A, Allavena P, Santoro G, Fumarulo R, Corsi MM and Mantovani A: Molecular pathways in cancer-related inflammation. Biochem Med (Zagreb). 21:264–275. 2011. View Article : Google Scholar
32	Perkins ND: Post-translational modifications regulating the activity and function of the nuclear factor κB pathway. Oncogene. 25:6717–6730. 2006. View Article : Google Scholar : PubMed/NCBI
33	Marzocco S, Adesso S, Alilou M, Stuppner H and Schwaiger S: Anti-inflammatory and anti-oxidant potential of the root extract and constituents of doronicum austriacum. Molecules. 22:10032017. View Article : Google Scholar
34	Witek P, Korga A, Burdan F, Ostrowska M, Nosowska B, Iwan M and Dudka J: The effect of a number of H9C2 rat cardiomyocytes passage on repeatability of cytotoxicity study results. Cytotechnology. 68:2407–2415. 2016. View Article : Google Scholar : PubMed/NCBI
35	Tu RH, Li QJ, Huang Z, He Y, Meng JJ, Zheng HL, Zeng ZY and Zhong GQ: Novel functional role of heat shock protein 90 in mitochondrial connexin 43-mediated hypoxic postconditioning. Cell Physiol Biochem. 44:982–997. 2017. View Article : Google Scholar : PubMed/NCBI
36	Vogel C and Marcotte EM: Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet. 13:2227–2232. 2012. View Article : Google Scholar
37	Wang J, Ma L, Tang X, Zhang X, Qiao Y, Shi Y, Xu Y, Wang Z, Yu Y and Sun F: Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells. Oncotarget. 6:24075–24091. 2015. View Article : Google Scholar : PubMed/NCBI
38	Balligand JL and Cannon PJ: Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences. Arterioscler Thromb Vasc Biol. 17:1846–1858. 1997. View Article : Google Scholar : PubMed/NCBI
39	Ahsan H: 3-Nitrotyrosine: A biomarker of nitrogen free radical species modified proteins in systemic autoimmunogenic conditions. Hum Immunol. 74:1392–1399. 2013. View Article : Google Scholar : PubMed/NCBI
40	Ye M, Zhang L, Yan Y and Lin H: Punicalagin protects H9c2 cardiomyocytes from doxorubicin-induced toxicity through activation of Nrf2/HO-1 signaling. Biosci Rep. 39:BSR201902292019. View Article : Google Scholar : PubMed/NCBI